NCT06837701

Brief Summary

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide. Many risk factors are thought to be important in the development of CVD; however, some risk factors can be controlled. Regular physical activity (PA) is recommended for the entire population for the primary prevention of CVD. PA and physical health are also believed to reduce other CVD risk factors such as body mass index, blood pressure and stress. Although oncological outcome is the most important factor for breast cancer survivors, CVD has emerged as an important cause of death among them. In particular, CVD mortality is known to increase 7 years after breast cancer diagnosis, and death due to CVD is more common in older patients than death from cancer. Higher levels of physical activity compared to low levels measured prior to breast cancer diagnosis were associated with statistically significantly lower all-cause mortality among women diagnosed with breast cancer. For breast cancer survivors, increasing PA during and after treatment has been reported to be safe and effective in improving cancer survival, alleviating cancer-related symptoms and improving quality of life. However, there is a lack of evidence regarding the effect of PA on cardiovascular outcomes in long-term breast cancer survivors.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jul 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 30, 2024

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

February 15, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 20, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 29, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2025

Completed
Last Updated

December 16, 2025

Status Verified

December 1, 2025

Enrollment Period

10 months

First QC Date

February 15, 2025

Last Update Submit

December 15, 2025

Conditions

Keywords

breast cancerCardiovascular diseasePhysical activity

Outcome Measures

Primary Outcomes (3)

  • Physical Activity Level

    Physical activity level was assessed using a multisensorial PA monitor. The SenseWear Armband (Armband Model MF-SW, BodyMedia, Pittsburgh, USA) was worn on the back of the left-side upper arm over the triceps for at least 7 consecutive days, except for times requiring contact with water, such as bathing and swimming. The monitor estimates energy expenditure using measurements from tri-axial accelerometers and sensors (galvanic skin response, heat flux, and skin temperature). The measured outputs of the SWA is step count

    One Year

  • Cardiovascular Disease Risk Scoring

    SCORE2

    One Year

  • Functional exercise capacity

    6 minutes walk test

    one year

Eligibility Criteria

Age40 Years - 80 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Study Population: Patients between the ages of 40-80 years who were diagnosed with breast cancer in Hacettepe University Hospital, Department of Internal Medicine, Department of Medical Oncology and volunteered to participate in the study will be included in the study.

You may qualify if:

  • To be between the ages of 40-80 years,
  • Volunteering to participate in the research,
  • At least 15 months after breast cancer surgery,
  • months after active breast cancer treatment (ie surgery/chemotherapy)
  • Having no problem in reading and/or understanding the scales and being able to cooperate with the tests.

You may not qualify if:

  • Presence of active infection,
  • Having a neurological disease or other clinical diagnosis that may affect cognitive status,
  • Having musculoskeletal and neurological disease, symptomatic heart disease, previous lung surgery and malignant disease that may affect exercise performance.
  • Presence of unstable hypertension or diabetes mellitus

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hacettepe University

Ankara, State, 06100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Breast NeoplasmsCardiovascular DiseasesMotor Activity

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesBehavior

Study Officials

  • Ebru Calik Kutukcu, PhD

    Hacettepe University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

February 15, 2025

First Posted

February 20, 2025

Study Start

July 30, 2024

Primary Completion

May 29, 2025

Study Completion

September 15, 2025

Last Updated

December 16, 2025

Record last verified: 2025-12

Locations